Arkolith/Insider Trading/TWST/Form 4

Finn Patrick John

President and COOTwist Bioscience Corp (TWST) · full profile →Form 4 · filed Feb 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$263K
Net Open-Market Flow
-$263K
Transactions
10
6 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2026Sell(S)2K$50.04$88K306K
Feb 13, 2026Option exercise(M)500$23.33$12K307K
Feb 13, 2026Option exercise(M)712$26.66$19K308K
Feb 12, 2026Option exercise(M)2K$26.66$40K310K
Feb 12, 2026Sell(S)4K$50.23$176K307K
Feb 12, 2026Option exercise(M)1K$23.33$23K309K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2026Option exercise(M)712—$032K
Feb 13, 2026Option exercise(M)500—$018K
Feb 12, 2026Option exercise(M)2K—$033K
Feb 12, 2026Option exercise(M)1K—$019K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-002041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML